Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial
The Lancet Neurology,  Clinical Article

Hankey GJ et al. – The findings support the hypothesis that antiplatelet therapy modifies the potential benefits of lowering homocysteine with B–vitamin supplementation in the secondary prevention of major vascular events. If validated, B vitamins might have a role in the prevention of ischaemic events in high–risk individuals with an allergy, intolerance, or lack of indication for antiplatelet therapy.

Methods
  • In the VITATOPS trial, 8164 patients with recent stroke or transient ischaemic attack were randomly allocated to double–blind treatment with one tablet daily of placebo or B vitamins (2 mg folic acid, 25 mg vitamin B6, and 500 μg vitamin B12) and followed up for a median 3•4 years (IQR 2•0—5•5) for the primary composite outcome of stroke, myocardial infarction, or death from vascular causes.
  • In the post–hoc analysis of the interaction between antiplatelet therapy and the effects of treatment with B vitamins on the primary outcome, the authors used Cox proportional hazards regression before and after adjusting for imbalances in baseline prognostic factors in participants who were and were not taking antiplatelet drugs at baseline and in participants assigned to receive B vitamins or placebo.
  • The authors also assessed the interaction in different subgroups of patients and different secondary outcomes.
  • At baseline, 6609 patients were taking antiplatelet therapy and 1463 were not.

Results
  • Patients not receiving antiplatelet therapy were more likely to be younger, east Asian, and disabled, to have a haemorrhagic stroke or cardioembolic ischaemic stroke, and to have a history of hypertension or atrial fibrillation.
  • They were less likely to be smokers and to have a history of peripheral artery disease, hypercholesterolaemia, diabetes, ischaemic heart disease, and a revascularisation procedure.
  • Of the participants taking antiplatelet drugs at baseline, B vitamins had no significant effect on the primary outcome (488 patients in the B–vitamins group [15%] vs 519 in the placebo group [16%]; hazard ratio [HR] 0.94, 95% CI 0.83—1.07).
  • By contrast, of the participants not taking antiplatelet drugs at baseline, B vitamins had a significant effect on the primary outcome (123 in the B–vitamins group [17%] vs 153 in the placebo group [21%]; HR 0.76, 0.60—0.96).
  • The interaction between antiplatelet therapy and the effect of B vitamins on the primary outcome was significant after adjusting for imbalance in the baseline variables (adjusted p for interaction=0.0204).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Cardiology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Cardiology Articles

1 Beta-blockers in heart failure with preserved ejection fraction: A meta-analysis Heart Failure Reviews, July 28, 2014    Evidence Based Medicine    Review Article    Clinical Article

2 Egg consumption and cardiovascular disease among diabetic individuals: a systematic review of the literature Full Text Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, July 30, 2014    Free full text    Review Article

3 Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure Circulation: Heart Failure, July 24, 2014    Clinical Article

4 Statins in the elderly: an answered question Current Opinion in Cardiology, June 9, 2014    Evidence Based Medicine    Review Article    Clinical Article

5 Consumption of nuts and legumes and risk of stroke: a meta-analysis of prospective cohort studies Nutrition, Metabolism & Cardiovascular Diseases, July 25, 2014    Evidence Based Medicine    Clinical Article

6 Effects of six months of vitamin D supplementation in patients with heart failure: A randomized double-blind controlled trial Nutrition, Metabolism & Cardiovascular Diseases, May 2, 2014    Clinical Article

7 Long-term effect of antihypertensive drugs on the risk of new-onset atrial fibrillation: A longitudinal cohort study Hypertension Research, July 15, 2014    Clinical Article
Exclusive Author Commentary

8 Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: an updated meta-analysis International Journal of Cardiology, July 16, 2014    Evidence Based Medicine    Review Article    Clinical Article

9 HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborative European Heart Journal, July 7, 2014    Evidence Based Medicine    Clinical Article

10 Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: Final five-year follow-up of the SYNTAX trial European Heart Journal, May 28, 2014    Clinical Article

11 Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: A randomized, placebo-controlled trial Full Text Nutrition Journal, November 15, 2013    Free full text    Clinical Article

12 Effect of resveratrol on blood pressure: A meta-analysis of randomized controlled trials Clinical Nutrition, July 22, 2014    Clinical Article

13 Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population American Heart Journal, July 29, 2014    Clinical Article

14 Comparison of 5-year survival after acute myocardial infarction using angiotensin-converting enzyme inhibitor versus angiotensin II receptor blocker The American Journal of Cardiology, June 13, 2014    Clinical Article

15 Cost-effectiveness of apixaban versus warfarin and aspirin in sweden for stroke prevention in patients with atrial fibrillation Thrombosis Research, July 3, 2014    Clinical Article

16 Treatment discontinuations with new oral agents for long-term anticoagulation: insights from a meta-analysis of 18 randomized trials including 101,801 patients Mayo Clinic Proceedings, July 23, 2014    Evidence Based Medicine    Clinical Article

17 Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms Heart, July 9, 2014    Evidence Based Medicine    Clinical Article

18 Effects of nebivolol versus metoprolol on sodium sensitivity and renal sodium handling in hypertensive Hispanic postmenopausal women Hypertension, July 14, 2014    Clinical Article

19 Efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: A systematic review and meta-analysis of phase III trials European Journal of Vascular and Endovascular Surgery, July 1, 2014    Review Article

20 Atenolol versus non-atenolol beta-blockers for the treatment of hypertension: a meta analysis Canadian Journal of Cardiology, February 10, 2014    Evidence Based Medicine    Review Article    Clinical Article

Indexed Journals in Cardiology: American Heart Journal, American Journal of Cardiology, Circulationn, Heartmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close